Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review

References

• Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–965.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Rotavirus: Transmission 2021 [ Accessed 30/04/2021]. Available from: https://www.cdc.gov/rotavirus/about/transmission.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Rotavirus: symptoms 2021 [ Accessed 05/May/2021]. Available from: https://www.cdc.gov/rotavirus/about/symptoms.html
   Google Scholar
• Dornbusch HJ, Vesikari T, Guarino A, et al. Rotavirus vaccination for all children or subgroups only? Comment of the European Academy of Paediatrics (EAP) and the European Society for Paediatric Infectious Diseases (ESPID) recommendation group for rotavirus vaccination. Eur J Pediatr. 2020;179(9):1489–1493.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Weekly Epidmiological Record 2009 [Cited 30/March/2021]. Available from: https://www.who.int/wer/2009/wer8450.pdf
   Google Scholar
• Steele AD, Madhi SA, Cunliffe NA, et al. Incidence of rotavirus gastroenteritis by age in African, Asian and European children: relevance for timing of rotavirus vaccination. Hum Vaccines Immunother. 2016;12(9):2406–2412.
   PubMed Web of Science ®Google Scholar
• Aliabadi N, Antoni S, Mwenda JM, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health. 2019;7(7):e893–e903.
   PubMed Web of Science ®Google Scholar
• Pediatric ROTavirus European CommitTee (PROTECT) The paediatric burden of rotavirus disease in Europe. Epidemiol Infect. 2006. 0950–2688. Print
   Web of Science ®Google Scholar
• GlaxoSmithKline Biologicals. Rotarix Prescribing Information 2019 [Cited 12/May/2021]. Available from: https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Rotarix/pdf/ROTARIX-PI-PIL.PDF
   Google Scholar
• Merck Sharp & Dohme Corp. RotaTeq prescribing Information 2020 [ Accessed 30/04/2021]. Available from: https://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf
   Google Scholar
• World Health Organization. Rotavirus Vaccines: WHO position paper 2007 [Accessed 19/March/2022]. Available from: https://apps.who.int/iris/bitstream/handle/10665/240983/WER8232_285-295.PDF.
   Google Scholar
• Poelaert D, Pereira P, Gardner R, et al. A review of recommendations for rotavirus vaccination in Europe: arguments for change. Vaccine. 2018;36(17):2243–2253.
   PubMed Web of Science ®Google Scholar
• ERR News. Algab väikelaste vaktsineerimine rotaviiruse vastu 2014 [Cited 19/March/2022]. Available from: https://www.err.ee/514868/algab-vaikelaste-vaktsineerimine-rotaviiruse-vastu
   Google Scholar
• LIKUMI. Vakcinācijas noteikumi 2022. [ Accessed 19/March/2022]. Available from: https://likumi.lv/ta/id/11215-vakcinacijas-noteikumi
   Google Scholar
• Terveyden ja Hyvinvoinnin Laitos. Infektiotaudit Ja Rokotukset Milloin Eri Rokotukset Ovat Alkaneet Suomessa? 2022 [Cited 19/March/2022]. Available from: https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/tietoa-rokotuksista/kansallinen-rokotusohjelma/milloin-eri-rokotukset-ovat-alkaneet-suomessa-
   Google Scholar
• National Immunisation Office. Rotavirus: the Disease and The Vaccine 2022 [ Accessed 19/March/2022]. Aviailable from: https://www.hse.ie/eng/health/immunisation/hcpinfo/othervaccines/rotavirus/?msclkid=0a70297fba3f11ecb8cb8a316c7e8b50
   Google Scholar
• Gov UK Rotavirus immunisation programme for infants 2021 [ Accessed 19/March/2022]. Accessed https://www.gov.uk/government/collections/rotavirus-vaccination-progarmme-for-infants?msclkid=909d34a9ba4211ecb8d65e2dfe12f959
   Google Scholar
• World Health Organization. Vaccine introduction in Germany 2021 [ Accessed 19/March/2022]. Available from: https://immunizationdata.who.int/pages/vaccine-intro-by-country/deu.html?YEAR=
   Google Scholar
• Nacionalinis visuomenes sveikatos centras prie Sveikatos apsaugos ministerijos. Kitąmet vaikai bus skiepijami nuo rotavirusinės infekcijos 2017 [ Accessed 19/March/2022]. Available from: https://nvsc.lrv.lt/lt/naujienos/kitamet-vaikai-bus-skiepijami-nuo-rotavirusines-infekcijos
   Google Scholar
• Gov PL Komunikat w sprawie realizacji szczepień przeciwko rotawirusom w ramach obowiązkowego Programu Szczepień Ochronnych na rok 2021 [ Accessed 19/March/2022]. Accessed https://www.gov.pl/web/zdrowie/komunikat-w-sprawie-realizacji-szczepien-przeciwko-rotawirusom-w-ramach-obowiazkowego-programu-szczepien-ochronnych-na-rok-2021
   Google Scholar
• DerStandard. Neuer Impfplan mit Impfpflicht 2006 [ Accessed 19/March/2022]. Available from: https://www.derstandard.at/story/2356614/neuer-impfplan-mit-impfpflicht
   Google Scholar
• Bundesminiterium Soziales, Gesundheit, Pflege und Konsumentenschutz. Rotavirus (Brechdurchfall) 2020 [Cited 19/March/2022]. Available from: https://www.sozialministerium.at/Themen/Gesundheit/Uebertragbare-Krankheiten/Infektionskrankheiten-A-Z/Rotavirus-(Brechdurchfall).html
   Google Scholar
• Bundesminiterium Soziales, Gesundheit, Pflege und Konsumentenschutz., 2022 [Cited 19/March/2022]. Available from: sozialministerium.at/Themen/Gesundheit/Impfen/Kostenfreies-Kinderimpfprogramm.html
   Google Scholar
• Agenzia italiana del farmaco. Il calendario vaccinale del Piano Nazionale di Prevenzione Vaccinale 2017-2019 2019 [ Accessed 19/March/2022]. Available from: https://www.salute.gov.it/imgs/C_17_pagineAree_4829_listaFile_itemName_0_file.pdf
   Google Scholar
• Υγείας Υ. Εθνικό Πρόγραμμα Εμβολιασμών Παιδιών και Εφήβων 2022 [ Accessed 19/March/2022]. Available from: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko-programma-emboliasmwn-epe-paidiwn-kai-efhbwn/10289-ethniko-programma-emboliasmwn-paidiwn-kai-efhbwn-2022
   Google Scholar
• World Health Organization. Vaccine introduction in Albania 2021 [ Accessed 19/March/2022]. Available from: https://immunizationdata.who.int/pages/vaccine-intro-by-country/alb.html?YEAR=
   Google Scholar
• World Health Organization. Vaccine introduction in Luxembourg 2021 [ Accessed 19/March/2022]. Available from: https://immunizationdata.who.int/pages/vaccine-intro-by-country/lux.html?YEAR=
   Google Scholar
• Folkhälsomyndigheten. Barnvaccinationsprogrammet i Sverige 2019 – Årsrapport 2019 [ Accessed 19/March/2022]. Available from: https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/b/barnvaccinationsprogrammet-i-sverige-2019/
   Google Scholar
• Folkhelseinstituttet. Rotavirusvaksine - veileder for helsepersonell 2019 [ Accessed 19/March/2022]. Available from: https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/rotavirusvaksinasjon—veileder-for/
   Google Scholar
• World Health Organization. Vaccine introduction in Bulgaria 2021 [ Accessed 13/March/2022]. Available from: https://immunizationdata.who.int/pages/vaccine-intro-by-country/bgr.html?YEAR=
   Google Scholar
• Mинистерство на здравеопазването. Национална програма за контрол и лечение на ротавирусните гастроентерити в Република България 2017-2021 г 2021 [ Accessed 13/March/2022]. Available from: https://www.strategy.bg/StrategicDocuments/View.aspx?lang=bg-BG&Id=1221
   Google Scholar
• Higgins JPT TJ, Chandler J, Cumpston M, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane, 2021. [Cited 11/May/2021]. Available from: www.training.cochrane.org/handbook
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies–report of the ISPOR task force on retrospective databases. Value Health. 2003;6(2):90–97.
   PubMed Web of Science ®Google Scholar
• Hungerford DA-O, Vivancos R, Read JM, et al. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16(10). DOI:10.1186/s12916-017-0989-z.
   PubMedGoogle Scholar
• Martinon-Torres F, Martinon-Torres N, Bouzon Alejandro M, et al. Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain [Research Support, Non-U.S. Gov’t]. Hum Vaccines Immunother. 2012;8(7):946–952.
   PubMed Web of Science ®Google Scholar
• Orrico-Sanchez A, Lopez-Lacort M, Perez-Vilar S, et al. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. BMC Infect Dis. 2017;17(1). DOI: 10.1186/s12879-017-2380-2.
   PubMedGoogle Scholar
• Redondo O, Cano R, Simon L. Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain. Hum Vaccines Immunother. 2015;11(3):769–775.
   PubMed Web of Science ®Google Scholar
• Bruun T, Salamanca BV, Bekkevold T, et al. Impact of the rotavirus vaccination program in Norway after four years with high coverage. Pediatr Infect Dis J. 2021;40(4):368–374.
   PubMed Web of Science ®Google Scholar
• Coveney J, Barrett M, Fitzpatrick P, et al. National rotavirus vaccination programme implementation and gastroenteritis presentations: the paediatric emergency medicine perspective. Ir J Med Sci. 2020;189(1):327–332.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Uhari M, Renko M, et al. Impact and effectiveness of rotateq vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013;32(12):1365–1373.
   PubMed Web of Science ®Google Scholar
• Leino T, Ollgren J, Salo H, et al. First year experience of rotavirus immunisation programme in Finland. Vaccine. 2012;31(1):176–182.
   PubMed Web of Science ®Google Scholar
• Leino T, Baum U, Scott P, et al., Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare. Vaccine. 35(42): 5611–5617. 2017.
   PubMed Web of Science ®Google Scholar
• Hartwig S, Uhari M, Renko M, et al. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq [Multicenter Study Observational Study Research Support, Non-U.S. Gov’t]. BMC Health Serv Res. 2014;14:632.
   PubMed Web of Science ®Google Scholar
• Solastie A, Leino T, Ollgren J. Success of rotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness. Vaccine. 2020;38(21):3766–3772.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Walker JL, Fenty J, et al. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted. Vaccine. 2017;35(4):680–686.
   PubMed Web of Science ®Google Scholar
• Vaas HJ, Tamm E Impact of the national rotavirus immunisation programme on hospitalisation of children with all- cause and rotaviral gastroenteritis. ESPID 37th Annual Meeting, Ljubljana, Solvenia, May 6–11 2019.
   Google Scholar
• Koivumagi K, Toompere K, Soeorg H, et al. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus. Vaccine. 2020;38(13):2879–2886.
   PubMed Web of Science ®Google Scholar
• Paulke-Korinek M, Kollaritsch H, Aberle SW, et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine. 2013;31(24):2686–2691.
   PubMed Web of Science ®Google Scholar
• Forrest R, Jones L, Willocks L, et al. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study. Arch Dis Child. 2017;102(4):323–327.
   PubMed Web of Science ®Google Scholar
• Redondo-Gonzalez O, Tenias-Burillo JM, Ruiz-Gonzalo J. Impact of self-financed rotavirus vaccines on hospital stays and costs in Spain after a 3-year introductory period. Epidemiol Infect. 2017;145(9):1773–1785.
   PubMed Web of Science ®Google Scholar
• Heggie R, Murdoch H, Cameron C, et al. Cost-impact study of rotavirus vaccination programme in Scotland. Hum Vaccines Immunother. 2019;15(6):1265–1271.
   PubMed Web of Science ®Google Scholar
• Restivo V, Caracci F, Sannasardo CE, et al. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily [Research Support, Non-U.S. Gov’t]. Acta Biomed Ateneo Parmense. 2018;89(3):437–442.
   Google Scholar
• Costantino C, Restivo V, Tramuto F, et al. Universal rotavirus vaccination program in Sicily: reduction in health burden and cost despite low vaccination coverage. Hum Vaccines Immunother. 2018;14(9):2297–2302.
   PubMed Web of Science ®Google Scholar
• Crealey M, Hayden J, Delaney I, et al. Hospitalisation with rotavirus gastroenteritis before and after rotavirus vaccine introduction [Conference Abstract]. Arch Dis Child. 2019;104(Supplement 3):A107.
   Google Scholar
• Gil-Prieto R, Gonzalez-Escalada A, Alvaro-Meca A, et al. Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirus infections in Spain. Vaccine. 2013;31(43):5000–5004.
   PubMed Web of Science ®Google Scholar
• Pietsch C, Liebert UG. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany. Clin Microbiol Infect. 2019;25(1):102–106.
   PubMed Web of Science ®Google Scholar
• Atchison CJ, Stowe J, Andrews N, et al. Rapid declines in age group-specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and wales. J Infect Dis. 2016;213(2):243–249.
   PubMed Web of Science ®Google Scholar
• Uhlig U, Kostev K, Schuster V, et al. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines. Pediatr Infect Dis J. 2014;33(11):e299–e304.
   PubMed Web of Science ®Google Scholar
• Sabbe M, Berger N, Blommaert A, et al. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. Eurosurveillance. 2016;21(27). DOI:10.2807/1560-7917.ES.2016.21.27.30273.
   Web of Science ®Google Scholar
• Hemming M, Räsänen S, Huhti L, et al. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172(6):739–746.
   PubMed Web of Science ®Google Scholar
• Armstrong G, Gallagher N, Cabrey P, et al. A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population. Vaccine. 2016;34(39):4718–4723.
   PubMed Web of Science ®Google Scholar
• Raes M, Strens D, Vergison A, et al. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium [Research Support, Non-U.S. Gov’t]. Pediatr Infect Dis J. 2011;30(7):e120–125.
   PubMed Web of Science ®Google Scholar
• Standaert B, Alwan A, Strens D, et al. Improvement in hospital quality of care (Qoc) after the introduction of rotavirus vaccination: an evaluation study in Belgium. Hum Vaccines Immunother. 2015;11(9):2266–2273.
   PubMed Web of Science ®Google Scholar
• Kittel PA. The impact of the recommendation of routine rotavirus vaccination in Germany: an interrupted time-series analysis [Observational Study]. Vaccine. 2018;36(2):243–247.
   PubMed Web of Science ®Google Scholar
• Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28(47):7507–7513.
   PubMed Web of Science ®Google Scholar
• Marquis A, Koch J. Impact of Routine Rotavirus Vaccination in Germany: evaluation Five Years After Its Introduction. Pediatr Infect Dis J. 2020;39(7):e109–e116.
   PubMed Web of Science ®Google Scholar
• Paulke-Korinek M, Rendi-Wagner P, Kundi M, et al. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J. 2010;29(4):319–323.
   PubMed Web of Science ®Google Scholar
• Hanquet G, Ducoffre G, Vergison A, et al. Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 2011;29(29–30):4698–4703.
   PubMed Web of Science ®Google Scholar
• Standaert B, Strens D, Li X, et al. The sustained rotavirus vaccination impact on nosocomial infection, duration of hospital stay, and age: the rotabis study (2005-2012). Infect Dis Ther. 2016;5(4):509–524.
   PubMed Web of Science ®Google Scholar
• Zlamy M, Kofler S, Orth D, et al. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis. 2013;13(1). DOI:10.1186/1471-2334-13-112.
   PubMedGoogle Scholar
• Inns T, Trindall A, Dunling-Hall S, et al. Introduction of a new Rotavirus vaccine: initial results of uptake and impact on laboratory confirmed cases in Anglia and Essex, United Kingdom. Hum Vaccines Immunother. 2015 [Jul];12(4):1040–1044.
   PubMed Web of Science ®Google Scholar
• Marlow R, Muir P, Vipond B, et al. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom. Eurosurveillance. 2015;20(48). DOI: 10.2807/1560-7917.ES.2015.20.48.30077.
   Web of Science ®Google Scholar
• Perez-Rubio A, Luquero FJ, Bachiller Luque MR, et al. Impact of the rotavirus vaccine in Valladolid, Spain: an interrupted time series analysis. Trials Vaccinol. 2016;5:84–87.
   Google Scholar
• Marlow RL M, Vipond B, Muir P, et al. Assessing the ongoing impact of rotavirus vaccination in the United Kingdom. ESPID 37th Annual Meeting, Ljubljana, Slovenia, May 6–11 2019.
   Google Scholar
• Akhtar T, Cargill J, Gerrard C, et al. Detection of rotavirus in paediatric oncology patients with diarrhoea: the impact of rotavirus vaccine. J Hosp Infect. 2018;99(2):185–187.
   PubMed Web of Science ®Google Scholar
• Standaert B, Van De Mieroop E, Nelen V. Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis. BMJ Open. 2015;5(6):e007453.
   PubMed Web of Science ®Google Scholar
• Ask LS, Liu C, Gauffin K, et al. The effect of rotavirus vaccine on socioeconomic differentials of paediatric care due to gastroenteritis in Swedish infants. Int J Environ Res Public Health. 2019;16(7):1095.
   PubMed Web of Science ®Google Scholar
• Braeckman T, Van Herck K, Raes M, et al. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J. 2011;30(SUPPL. 1):S21–S24.
   PubMed Web of Science ®Google Scholar
• Raes MS D, Benninghof B, Pereira P, et al. ESPID 38th Annual Meeting (Virtual Meeting). October 26-29 2020.
   Google Scholar
• Álvarez Aldeán J, Ares Segura S, Díaz González C, et al. Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM) Recomendaciones para la vacunación frente al ROTAvirus de los recién nacidos PREMaturos (ROTAPREM). Anales de Pediatría. 2019;91(3):205.e1–205.e7.
   PubMedGoogle Scholar
• Zeevat F, Dvortsin E, Wondimu A, et al. Rotavirus vaccination of infants delayed and limited within the national immunization programme in the Netherlands: an opportunity lost. Vaccines (Basel). 2021;9(2):144.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine. 2015;33(18):2097–2107.
   PubMed Web of Science ®Google Scholar
• Burnett E, Parashar UD, Tate JE. Global impact of Rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019. J Infect Dis. 2020;222(10):1731–1739.
   PubMed Web of Science ®Google Scholar
• Lopez-Lacort M, Orrico-Sanchez A, Martinez-Beneito MA, et al. Spatio-temporal impact of self-financed rotavirus vaccination on rotavirus and acute gastroenteritis hospitalisations in the Valencia region, Spain. BMC Infect Dis. 2020;20(1). DOI: 10.1186/s12879-020-05373-0.
   Web of Science ®Google Scholar
• Mast TC, Heyman D, Dasbach E, et al. Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: an example using rotavirus vaccines with potential application to SARS-CoV-2. Vaccine. 2021;7:100084.
   Web of Science ®Google Scholar
• Baker JM, Dahl RM, Cubilo J, et al., Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001–2016. BMC Infect Dis. 19(1): 186. 2019.
   PubMedGoogle Scholar
• Lopman BA, Curns A, Yen C, et al., Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis. 204(7): 980–986. 2011.
   PubMed Web of Science ®Google Scholar
• Díez-Domingo J, Garcés-Sánchez M, Giménez-Sánchez F, et al. What have we learnt about rotavirus in Spain in the last 10 years? Anales de Pediatría. 2019;91(3):166–179.
   PubMed Web of Science ®Google Scholar
• Ruiz-Contreras J, Alfayate-Miguelez S, Carazo-Gallego B, et al. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013–2018. BMC Infect Dis. 2021;21(1). DOI:10.1186/s12879-021-06841-x.
   PubMed Web of Science ®Google Scholar
• Jayasinghe S, Macartney K. Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia. Vaccine. 2013;31(6):967–972.
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows 2021 [ Accessed November/26/2021]. Available from: https://www.who.int/news/item/15-07-2021-covid-19-pandemic-leads-to-major-backsliding-on-childhood-vaccinations-new-who-unicef-data-shows*Data indicate that the COVID19 pandemic had a*Data indicate that the COVID19 pandemic had a significant impact on routine vaccinations worldwide.
   Google Scholar
• DeSilva MB, Haapala J, Vazquez-Benitez G, et al. Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the vaccine safety datalink. JAMA Pediatr. 2022;176(1):68–77.
   PubMed Web of Science ®Google Scholar
• Kujawski SA, Yao L, Wang HE, et al. Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: a database analysis. Vaccine. 2022;40(5):706–713.
   PubMed Web of Science ®Google Scholar
• Scarano SM, Lo Vecchio A. How to make up for Rotavirus vaccination missed during the COVID-19 pandemic? JAMA Pediatr. 2022;176(4):420.
   Web of Science ®Google Scholar
• Bell S, Clarke R, Paterson P, et al. Parents’ and guardians’ views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: a mixed methods study in England. PLOS ONE. 2021;15(12):e0244049.
   Web of Science ®Google Scholar
• Causey K, Fullman N, Sorensen RJD, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021;398(10299):522–534.
   PubMed Web of Science ®Google Scholar
• McDonald HI, Tessier E, White JM, et al. Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020. Euro Surveillance. 2020;25(19):2000848. bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
   PubMedGoogle Scholar
• Bouzón Alejandro M, Diez Domingo J, Martinón-Torres F, et al. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain. Hum Vaccin. 2011;7(7):798–799.
   PubMedGoogle Scholar
• Martinón-Torres F, Aramburo A, Martinón-Torres N, et al. A reverse evidence of rotavirus vaccines impact. Hum Vaccines Immunother. 2013;9(6):1289–1291.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines WHO position paper – January 2013 2013. [Accessed 2021 November 26]. Available from: https://apps.who.int/iris/bitstream/handle/10665/242024/WER8805_49-64.PDF?sequence=1&isAllowed=y
   Google Scholar
• European Centre for Disease Prevention and Control. Vaccine scheduler. Rotavirus infection: recommended vaccinations 2021 [ Accessed November/26/2021]. Available from: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=32&SelectedCountryIdByDisease=−1
   Google Scholar
• Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. Vaccine. 2018;36(33):4979–4992.
   PubMed Web of Science ®Google Scholar